Parker Waichman, a national law firm, has now filed five (5) separate lawsuits where each Plaintiff alleged that he or she developed NAION after taking Novo Nordisk's Ozempic or Wegovy
Parker Waichman has now filed multiple lawsuits in New Jersey state court on behalf of victims who were prescribed Ozempic or Wegovy and developed NAION, an irreversible eye condition that causes partial or complete permanent vision loss in one or both eyes. Most recently, on August 7, 2025, the Firm filed a lawsuit on behalf of a 60-year Miami, Florida resident who developed NAION after taking Ozempic. See Delgado v. Novo Nordisk Inc., Docket No: MID-L-0047-25. To most efficiently litigate these cases, Parker Waichman LLP recently joined four other law firms and filed an application to the New Jersey Supreme Court to consolidate all New Jersey state lawsuits alleging permanent vision loss from use of Ozempic/Wegovy products in Middlesex County, New Jersey.
https://mma.prnewswire.com/media/2474034/Parker_Waichman_Logo_Logo.jpg
Parker Waichman continues to file additional cases and urges individuals who have sufferedserious eye injuriesafter taking these widely prescribed GLP-1 receptor agonist medications to contact them for afree case review. These medications, originally developed to treat Type 2 diabetes, have surged in popularity for weight loss. However, recent studies have uncovered adisturbing link between semaglutide (Ozempic/Wegovy) and NAION, a condition that causes permanent vision loss by cutting off blood flow to the optic nerve. Patients who took these drugs have reportedsudden blindness, optic nerve damage, and other irreversible complications, raising concerns about thefailure of drug manufacturers to warn consumers and medical professionalsabout these risks.
A2025 study published in JAMA Ophthalmologyexaminednine patientswho developedoptic nerve disordersafter using GLP-1 medications, with the majority suffering from NAION-like symptoms. Additional research fromHarvard's Mass Eye and Ear Institutefound thatdiabetic users of semaglutide were four times more likely to develop NAION, while non-diabetic users taking the drug for weight loss faced asevenfold increased risk.
Despite growing scientific evidence,Novo Nordisk continues to downplay the dangersassociated with these medications, failing to includeadequate warningsabout the risk of permanent blindness.
Parker Waichman LLP Fights for Victims Nationwide
“NAION is a devastating, and permanent, eye injury diagnosis. Studies from multiple, reputable institutions, have shown a statistically significant relationship between semaglutide (the active ingredient in Ozempic and Wegovy) and NAION. Despite this evidence, Novo Nordisk continues to deny reality by failing to warn consumers and medical professionals about this horrific injury and must be held accountable,”saidJason S. Goldstein, Senior Litigation Counsel at Parker Waichman LLP.
Parker Waichman LLP iscurrently accepting cases nationwidefor individuals who have suffered vision loss, blindness, or serious optic nerve damage after takingOzempic or Wegovy. Victims may be entitled tocompensation for medical expenses, lost wages, pain and suffering, and other damages.
Free Case Review for Affected Individuals
If you or a loved oneexperienced sudden vision loss, blindness, or optic nerve damageafter usingOzempic or Wegovy, you may have alegal claim against the drug manufacturers. Parker Waichman LLP is offeringfree, no-obligation case evaluationsto help victims understand their rights and pursue justice.
Contact Parker Waichman LLP Today
For a free consultation, call 1-800-YOUR-LAWYER (1-800-968-7529) or visit YourLawyer.com to learn more about your legal options and how to protect your rights.
About Parker Waichman LLP
Parker Waichman LLP is a nationally recognized law firm dedicated to fighting for victims ofdefective drugs, dangerous products, accidents, and corporate negligence. Specifically, the Firm is quite experienced in representing eye injury victims due to the negligence of pharmaceutical companies. Representative cases include In Re Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation and Bausch & Lomb Contact Lens Solutions Prod. Liab. Litig. With a proven track record ofholding pharmaceutical companies accountable, the firm has securedbillions in settlements and verdictsfor injured clients.
Media Contact:
Parker Waichman LLPPhone:1-800-YOUR-LAWYER (1-800-968-7529)Website:www.yourlawyer.com
https://c212.net/c/img/favicon.png?sn=NY50825&sd=2025-08-13
View original content to download multimedia:https://www.prnewswire.com/news-releases/parker-waichman-llp-files-lawsuit-on-behalf-of-florida-woman-alleging-development-of-irreversible-eye-condition-naion-after-taking-ozempic-302529163.html
SOURCE Parker Waichman LLP
https://rt.newswire.ca/rt.gif?NewsItemId=NY50825&Transmission_Id=202508131136PR_NEWS_USPR_____NY50825&DateId=20250813